Oral contraceptive use and incident urinary incontinence in premenopausal women
- PMID: 19296979
- PMCID: PMC2712870
- DOI: 10.1016/j.juro.2009.01.040
Oral contraceptive use and incident urinary incontinence in premenopausal women
Abstract
Purpose: Recent data in postmenopausal women indicate that current and past use of exogenous hormones is related to urinary incontinence risk. Little is known about exogenous hormones and risk of urinary incontinence in younger women. We investigated the association between oral contraceptive pills and incident urinary incontinence in premenopausal women enrolled in the Nurses' Health Study II.
Materials and methods: Participants reported use of oral contraceptive pills from 1989 to 2001. Among 21,864 premenopausal women 37 to 54 years old reporting no urinary incontinence in 2001 we identified 749 with incident urinary incontinence at least weekly between 2001 and 2003. Odds ratios and 95% confidence intervals were estimated using multivariable logistic regression.
Results: Women who had ever used oral contraceptive pills had a statistically significant 27% (95% CI 1-59) increased odds of experiencing urinary incontinence at least weekly compared with those who never used oral contraceptive pills. In women with 10 or more years of use the odds ratio increased to 1.48 (95% CI 1.13-1.95). Ever using oral contraceptive pills was specifically associated with urgency urinary incontinence (OR 2.48, 95% CI 1.07-5.76) rather than stress urinary incontinence (OR 1.04, 95% CI 0.78-1.40). Although we had limited information on urinary tract infection, control for urinary tract infection did not alter these findings.
Conclusions: Use of oral contraceptive pills may be associated with a modest increase in the odds of urinary incontinence among premenopausal women. However, this is one of the first reports of such an association and, thus, further research is needed to confirm our findings and investigate possible mechanisms.
Figures
Comment in
-
Exogenous estrogen and urinary incontinence.J Urol. 2009 May;181(5):1989-91. doi: 10.1016/j.juro.2009.02.047. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286197 No abstract available.
Similar articles
-
Postmenopausal hormone therapy and risk of developing urinary incontinence.Obstet Gynecol. 2004 Feb;103(2):254-60. doi: 10.1097/01.AOG.0000107290.33034.6f. Obstet Gynecol. 2004. PMID: 14754692
-
Associations Between Type and Route of Hormone Use on Urinary Incontinence and Pelvic Organ Prolapse in Premenopausal and Postmenopausal Women.Female Pelvic Med Reconstr Surg. 2018 Mar/Apr;24(2):100-104. doi: 10.1097/SPV.0000000000000493. Female Pelvic Med Reconstr Surg. 2018. PMID: 28953079
-
Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women.Am J Obstet Gynecol. 2009 Jan;200(1):86.e1-5. doi: 10.1016/j.ajog.2008.08.009. Epub 2008 Nov 18. Am J Obstet Gynecol. 2009. PMID: 19019333 Free PMC article.
-
Steroidal contraceptives and bone fractures in women: evidence from observational studies.Cochrane Database Syst Rev. 2012 Aug 15;(8):CD009849. doi: 10.1002/14651858.CD009849.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2015 Jul 21;(7):CD009849. doi: 10.1002/14651858.CD009849.pub3. PMID: 22895991 Updated. Review.
-
Progestin-only pills for contraception.Cochrane Database Syst Rev. 2013 Nov 13;(11):CD007541. doi: 10.1002/14651858.CD007541.pub3. Cochrane Database Syst Rev. 2013. PMID: 24226383 Review.
Cited by
-
Utility of opportunistic screening to assess the impact of urinary incontinence on quality of life and barriers to seeking treatment among women attending a tertiary healthcare centre in North India.BMC Urol. 2024 Mar 2;24(1):50. doi: 10.1186/s12894-024-01434-7. BMC Urol. 2024. PMID: 38431583 Free PMC article.
-
Sexual Health Behaviors by Age 17 and Lower Urinary Tract Symptoms at Age 19: PLUS Research Consortium Analysis of ALSPAC Data.J Adolesc Health. 2023 May;72(5):737-745. doi: 10.1016/j.jadohealth.2022.12.019. Epub 2023 Feb 11. J Adolesc Health. 2023. PMID: 36781327 Free PMC article.
-
Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review.Res Rep Urol. 2020 May 7;12:179-185. doi: 10.2147/RRU.S249611. eCollection 2020. Res Rep Urol. 2020. PMID: 32440514 Free PMC article. Review.
-
The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.Front Cell Infect Microbiol. 2019 May 1;9:133. doi: 10.3389/fcimb.2019.00133. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31119104 Free PMC article. Review.
-
Risk factors for urinary incontinence among postmenopausal Mexican women.Int Urogynecol J. 2017 May;28(5):769-776. doi: 10.1007/s00192-016-3196-0. Epub 2016 Dec 16. Int Urogynecol J. 2017. PMID: 27987024
References
-
- Grodstein F, Lifford K, Resnick NM, Curhan GC. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol. 2004;103:254. - PubMed
-
- Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005;293:935. - PubMed
-
- Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B. The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol. 1993;149:1459. - PubMed
-
- Thom DH, van den Eeden SK, Brown JS. Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol. 1997;90:983. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
